tiprankstipranks
Waverley Pharma (TSE:WAVE)
TSXV:WAVE

Waverley Pharma (WAVE) Income Statement

2 Followers

Waverley Pharma Income Statement

Last quarter (Q4 2023), Waverley Pharma's total revenue was C$―, a decrease of -100.00% from the same quarter last year. In Q4, Waverley Pharma's net income was C$-264.13K. See Waverley Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ 293.40KC$ 412.09KC$ 1.54MC$ 1.75MC$ 1.38MC$ 1.16M
Cost of Revenue
C$ 215.42KC$ 332.29KC$ 963.04KC$ 1.53MC$ 1.19MC$ 1.11M
Gross Profit
C$ 77.98KC$ 79.80KC$ 581.78KC$ 222.67KC$ 181.71KC$ 48.94K
Operating Expense
C$ 2.20MC$ 2.31MC$ 1.22MC$ 1.01MC$ 891.31KC$ 1.46M
Operating Income
C$ -2.13MC$ -2.23MC$ -638.16KC$ -786.83KC$ -709.60KC$ -1.41M
Net Non Operating Interest Income Expense
C$ -97.38KC$ -76.65KC$ -16.64KC$ -3.04KC$ 5.39KC$ 45.99K
Other Income Expense
C$ -78.64KC$ -78.64K-C$ 6.64KC$ -1.55KC$ 152.87K
Pretax Income
C$ -2.15MC$ -2.22MC$ -664.08KC$ -796.51KC$ -705.76KC$ -1.21M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
C$ -2.15MC$ -2.22MC$ -664.08KC$ -796.51KC$ -705.76KC$ -1.21M
Basic EPS
C$ -0.03C$ -0.04C$ -0.01C$ -0.01C$ -0.01C$ -0.02
Diluted EPS
C$ -0.03C$ -0.04C$ -0.01C$ -0.01C$ -0.01C$ -0.02
Basic Average Shares
C$ 216.00MC$ 54.00MC$ 54.00MC$ 54.00MC$ 54.00MC$ 54.00M
Diluted Average Shares
C$ 216.00MC$ 54.00MC$ 54.00MC$ 54.00MC$ 54.00MC$ 54.00M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
C$ 2.42MC$ 2.64MC$ 2.18M-C$ 2.08MC$ 2.57M
Net Income From Continuing And Discontinued Operation
C$ -2.15MC$ -2.22MC$ -664.08KC$ -796.51KC$ -705.76KC$ -1.21M
Normalized Income
C$ -1.65MC$ -1.63MC$ -488.10KC$ -796.51KC$ -692.43KC$ -1.21M
Interest Expense
------
EBIT
C$ -2.05MC$ -2.15MC$ -647.44KC$ -799.54KC$ -709.60KC$ -1.41M
EBITDA
C$ -1.71MC$ -1.72MC$ -435.33K-C$ -701.43KC$ -1.41M
Currency in CAD

Waverley Pharma Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis